Genomic Characterization Revealed PM2.5-Associated Mutational Signatures in Lung Cancer Including Activation of APOBEC3B

Environ Sci Technol. 2023 May 2;57(17):6854-6864. doi: 10.1021/acs.est.2c08092. Epub 2023 Apr 18.

Abstract

Fine particulate matter (PM2.5) exposure causes DNA mutations and abnormal gene expression leading to lung cancer, but the detailed mechanisms remain unknown. Here, analysis of genomic and transcriptomic changes upon a PM2.5 exposure-induced human bronchial epithelial cell-based malignant transformed cell model in vitro showed that PM2.5 exposure led to APOBEC mutational signatures and transcriptional activation of APOBEC3B along with other potential oncogenes. Moreover, by analyzing mutational profiles of 1117 non-small cell lung cancers (NSCLCs) from patients across four different geographic regions, we observed a significantly higher prevalence of APOBEC mutational signatures in non-smoking NSCLCs than smoking in the Chinese cohorts, but this difference was not observed in TCGA or Singapore cohorts. We further validated this association by showing that the PM2.5 exposure-induced transcriptional pattern was significantly enriched in Chinese NSCLC patients compared with other geographic regions. Finally, our results showed that PM2.5 exposure activated the DNA damage repair pathway. Overall, here we report a previously uncharacterized association between PM2.5 and APOBEC activation, revealing a potential molecular mechanism of PM2.5 exposure and lung cancer.

Keywords: APOBEC3B; COSMIC mutational signatures; fine particulate matter; lung cancer; malignant transformation cell model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism
  • Epithelial Cells
  • Genomics
  • Humans
  • Lung Neoplasms* / pathology
  • Minor Histocompatibility Antigens / adverse effects
  • Minor Histocompatibility Antigens / metabolism
  • Mutation
  • Particulate Matter / adverse effects

Substances

  • Particulate Matter
  • APOBEC3B protein, human
  • Cytidine Deaminase
  • Minor Histocompatibility Antigens